Francesca Soutter

Francesca Soutter

Auto-generated profile, based on publicly available information

Francesca Soutter

Department of Pathobiology and Population Sciences, The Royal Veterinary College, University of London, Hatfield, Hertfordshire, UK

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2018 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
CACharalampos Attipa
Charalampos Attipa
LSLaia Solano-Gallego
Laia Solano-Gallego
KPKostas Papasouliotis
Kostas Papasouliotis
FSFrancesca Soutter
Francesca Soutter
DMDavid Morris
David Morris
Séverine TaskerSéverine Tasker
Séverine Tasker
In the Mediterranean basin, Leishmania infantum is a major cause of disease in dogs, which are frequently co-infected with other vector-borne pathogens (VBP). However, the associations between dogs with clinical leishmaniosis (ClinL) and VBP co-infections have not been studied. We assessed the risk of VBP infections in dogs with ClinL and healthy controls. We conducted a prospective case-control study of dogs with ClinL (positive qPCR and ELISA antibody for L. infantum on peripheral blood) and clinically healthy, ideally breed-, sex- and age-matched, control dogs (negative qPCR and ELISA antibody for L. infantum on peripheral blood) from Paphos, Cyprus. We obtained demographic data and all dogs underwent PCR on EDTA-blood extracted DNA for haemoplasma species, Ehrlichia/Anaplasma spp., Babesia spp., and Hepatozoon spp., with DNA sequencing to identify infecting species. We used logistic regression analysis and structural equation modelling (SEM) to evaluate the risk of VBP infections between ClinL cases and controls. From the 50 enrolled dogs with ClinL, DNA was detected in 24 (48%) for Hepatozoon spp., 14 (28%) for Mycoplasma haemocanis, 6 (12%) for Ehrlichia canis and 2 (4%) for Anaplasma platys. In the 92 enrolled control dogs, DNA was detected in 41 (45%) for Hepatozoon spp., 18 (20%) for M. haemocanis, 1 (1%) for E. canis and 3 (3%) for A. platys. No Babesia spp. or “Candidatus Mycoplasma haematoparvum” DNA was detected in any dog. No statistical differences were found between the ClinL and controls regarding age, sex, breed, lifestyle and use of ectoparasitic prevention. A significant association between ClinL and E. canis infection (OR = 12.4, 95% CI: 1.5–106.0, P = 0.022) was found compared to controls by multivariate logistic regression. This association was confirmed using SEM, which further identified that younger dogs were more likely to be infected with each of Hepatozoon spp. and M. haemocanis, and dogs with Hepatozoon spp. were more likely to be co-infected with M. haemocanis. Dogs with ClinL are at a higher risk of co-infection with E. canis than clinically healthy dogs. We recommend that dogs diagnosed with ClinL should be tested for E. canis co-infection using PCR.

10 July 2020 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
IFIvan Pastor Fernández
Ivan Pastor Fernández
SKSungwon Kim
Sungwon Kim
Virginia Marugan-HernandezVirginia Marugan-Hernandez
Virginia Marugan-Hernandez
FSFrancesca Soutter
Francesca Soutter
FTFiona M. Tomley
Fiona M. Tomley
DBDamer Blake
Damer Blake
Background: Poultry coccidiosis is a parasitic enteric disease with a highly negative impact on chicken production. In-feed chemoprophylaxis remains the primary method of control, but the increasing ineffectiveness of anticoccidial drugs, and potential future restrictions on their use has encouraged the use of commercial live vaccines. Availability of such formulations is constrained by their production, which relies on the use of live chickens. Several experimental approaches have been taken to explore ways to reduce the complexity and cost of current anticoccidial vaccines including the use of live vectors expressing relevantEimeriaproteins. We and others have shown that vaccination with transgenicEimeria tenellaparasites expressingEimeria maximaApical Membrane Antigen-1 or Immune Mapped Protein-1 (EmAMA1 andEmIMP1) partially reduces parasite replication after challenge with a low dose ofE. maximaoocysts. In the present study, we have reassessed the efficacy of these experimental vaccines using commercial birds reared at high stocking densities and challenged with both low and high doses ofE. maximato evaluate how well they protect chickens against the negative impacts of disease on production parameters.Methods: Populations ofE. tenellaparasites expressingEmAMA1 andEmIMP1 were obtained by nucleofection and propagated in chickens. Cobb500 broilers were immunised with increasing doses of transgenic oocysts and challenged two weeks later withE. maximato quantify the effect of vaccination on parasite replication, local IFN-γ and IL-10 responses (300 oocysts), as well as impacts on intestinal lesions and body weight gain (10,000 oocysts).Results: Vaccination of chickens withE. tenellaexpressingEmAMA1, or admixtures ofE. tenellaexpressingEmAMA1 orEmIMP1, was safe and induced partial protection against challenge as measured byE. maximareplication and severity of pathology. Higher levels of protection were observed when both antigens were delivered and was associated with a partial modification of local immune responses againstE. maxima, which we hypothesise resulted in more rapid immune recognition of the challenge parasites.Conclusions: This study offers prospects for future development of multivalent anticoccidial vaccines for commercial chickens. Efforts should now be focused on the discovery of additional antigens for incorporation into such vaccines.

1 March 2017 in Ticks and Tick-borne Diseases
Verified
Journal Article
Open access
CACharalampos Attipa
Charalampos Attipa
CHChelsea A.E. Hicks
Chelsea A.E. Hicks
Emi BarkerEmi Barker
Emi Barker
VCVasiliki Christodoulou
Vasiliki Christodoulou
KNKyriaki Neofytou
Kyriaki Neofytou
Séverine TaskerSéverine Tasker
Séverine Tasker
Canine tick-borne pathogens such as Ehrlichia canis and Hepatozoon canis are widespread in the Mediterranean basin but have never been reported or investigated in Cyprus. We describe herein the presence of canine tick-borne pathogens in three dogs with clinical signs compatible with vector-borne diseases from Paphos area of Cyprus. Molecular and phylogenetic analysis revealed the presence of E. canis, Anaplasma platys, H. canis, Babesia vogeli and Mycoplasma haemocanis in Cyprus. One dog co-infected with E. canis, H. canis, B. vogeli and M. haemocanis is, to the best of our knowledge, the first report of this multiple co-infection in dogs. The tick-borne pathogens reported in the current study should be considered in the differential diagnoses in dogs exposed to ticks in Cyprus.

18 September 2019 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
CACharalampos Attipa
Charalampos Attipa
LSLaia Solano-Gallego
Laia Solano-Gallego
CLChristian M. Leutenegger
Christian M. Leutenegger
KPKostas Papasouliotis
Kostas Papasouliotis
FSFrancesca Soutter
Francesca Soutter
Séverine TaskerSéverine Tasker
Séverine Tasker
Background: Dogs that have clinical leishmaniosis (ClinL), caused by the parasite Leishmania infantum, are commonly co-infected with other pathogens, especially vector-borne pathogens (VBP). A recent PCR-based study found that ClinL dogs are more likely to be additionally infected with the rickettsial bacteria Ehrlichia canis. Further information on co-infections in ClinL cases with VBP, as assessed by serology, is required. The research described in this report determined if dogs with ClinL are at higher risk of exposure to VBP than healthy control dogs using a case-control serology study. Results: Of the 47 dogs with ClinL, anti-E. canis/ Ehrlichia ewingii antibodies were detected in 17 (36.2%), anti-Anaplasma phagocytophilum/Anaplasma platys antibodies in 5 (10.6%) and antigen for Dirofilaria immitis in 2 (4.3%). Of the 87 control dogs, anti-E. canis/E. ewingii antibodies were detected in 14 (16.1%) and anti-A. phagocytophilum/A. platys antibodies in 2 (2.3%). No anti-Borrelia burgdorferi antibody tests were positive. No statistical differences between the ClinL dogs and control dogs regarding lifestyle or use of ectoparasitic prevention, were identified. The ClinL was significantly associated with anti-E. canis/E. ewingii antibodies (odds ratio = 2.9, 95% confidence interval: 1.3–6.7, P = 0.010) compared to controls by both multivariable logistic regression and structural equation modelling. Conclusions: It was demonstrated that an increased risk for E. canis/E. ewingii seropositivity is present in dogs with ClinL compared to clinically healthy control dogs, despite similar ectoparasitic prevention use and lifestyle. Based on these findings it is suggested that dogs with ClinL should not only be tested for E. canis co-infection using PCR but also serologically for E. canis/E. ewingii.

22 February 2021 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
FSFrancesca Soutter
Francesca Soutter
DWDirk Werling
Dirk Werling
SKSungwon Kim
Sungwon Kim
IFIvan Pastor Fernández
Ivan Pastor Fernández
Virginia Marugan-HernandezVirginia Marugan-Hernandez
Virginia Marugan-Hernandez
DBDamer Blake
Damer Blake
Eimeria species parasites infect the gastrointestinal tract of chickens, causing disease and impacting on production. The poultry industry relies on anticoccidial drugs and live vaccines to control Eimeria and there is a need for novel, scalable alternatives. Understanding the outcomes of experimental infection in commercial chickens is valuable for assessment of novel interventions. We examined the impact of different infectious doses of Eimeria tenella (one low dose, three high doses) in three commercial layer chicken lines, evaluating lesion score, parasite replication and cytokine response in the caeca. Groups of eight to ten chickens were housed together and infected with 250, 4,000, 8,000 or 12,000 sporulated oocysts at 21 days of age. Five days post-infection caeca were assessed for lesions and to quantify parasite replication by qPCR and cytokine transcription by RT-qPCR. Comparison of the three high doses revealed no significant variation between them in observed lesions or parasite replication with all being significantly higher than the low dose infection. Transcription of IFN-γ and IL-10 increased in all infected chickens relative to unchallenged controls, with no significant differences associated with dose magnitude (p > 0.05). No significant differences were detected in lesion score, parasite replication or caecal cytokine expression between the three lines of chickens. We therefore propose 4,000 E. tenella oocysts is a sufficient dose to reliably induce lesions in commercial layer chickens, and that estimates of parasite replication can be derived by qPCR from these same birds. However, more accurate quantification of Eimeria replication requires a separate low dose challenge group. Optimisation of challenge dose in an appropriate chicken line is essential to maximize the value of in vivo efficacy studies. For coccidiosis, this approach can reduce the numbers of chickens required for statistically significant studies and reduce experimental severity.

1 May 2019 in Veterinary Parasitology
Verified
Journal Article
Closed access
FSFrancesca Soutter
Francesca Soutter
LSLaia Solano-Gallego
Laia Solano-Gallego
CACharalampos Attipa
Charalampos Attipa
LGLuigi Gradoni
Luigi Gradoni
EFEleonora Fiorentino
Eleonora Fiorentino
BCBrian Catchpole
Brian Catchpole